Prevalence of Significant Hepatic Fibrosis and Cirrhosis Assessed by Various Non-Invasive Scores in Patients Attending the Diabetic Clinic

被引:0
作者
Chin, Jun Liong
Chan, Grace
Aftab, Abdur R.
McGurk, Colm
Courtney, Garry
机构
关键词
D O I
10.1016/S0016-5085(16)32073-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1975
引用
收藏
页码:S603 / S603
页数:1
相关论文
共 50 条
[21]   Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores [J].
Karlas, Thomas ;
Hempel, Maria ;
Troeltzsch, Michael ;
Huster, Dominik ;
Guenther, Peter ;
Tenckhoff, Hannelore ;
Moessner, Joachim ;
Berg, Thomas ;
Keim, Volker ;
Wiegand, Johannes .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (11) :1353-1361
[22]   Characterization of Biochemical Non-Invasive Liver Fibrosis Scores in Patients With Inflammatory Bowel Disease [J].
Patel, Anish ;
Shaha, Sneha ;
Cai, Cindy ;
Hammami, Muhammad B. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 :S430-S430
[23]   Non-invasive diagnostic screening of hepatic fibrosis in patients with chronic hepatitis B [J].
陈永鹏 ;
冯筱榕 ;
戴琳 ;
章廉 ;
侯金林 .
中华医学杂志(英文版), 2004, (07) :150-153
[24]   Screening for significant fibrosis using non-invasive biomarkers (FibroTest) in hyperlipidemic patients (HP) [J].
Munteanu, M ;
Giral, PH ;
Messous, D ;
Mercadier, A ;
Bernard, M ;
Ratziu, V ;
Morra, R ;
Imbert-Bismut, E ;
Bruckert, E ;
Poynard, T .
JOURNAL OF HEPATOLOGY, 2005, 42 :251-252
[25]   Usefulness of Non-invasive Markers for Predicting Significant Fibrosis in Patients with Chronic Liver Disease [J].
Lee, Han Hyo ;
Seo, Yeon Seok ;
Um, Soon Ho ;
Won, Nam Hee ;
Yoo, Hanna ;
Jung, Eun Suk ;
Kwon, Yong Dae ;
Park, Sanghoon ;
Keum, Bora ;
Kim, Yong Sik ;
Yim, Hyung Joon ;
Jeen, Yoon Tae ;
Chun, Hoon Jai ;
Kim, Chang Duck ;
Ryu, Ho Sang .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (01) :67-74
[26]   Predicting the Severity of Esophageal Varices in Patients with Hepatic Cirrhosis Using Non-Invasive Markers [J].
Du, Yang-Chun ;
Jiang, Dan ;
Wu, Ji .
RISK MANAGEMENT AND HEALTHCARE POLICY, 2023, 16 :1555-1566
[27]   From invasive to intuitive: The emerging role of non-invasive models in hepatic decompensation: Editorial on "Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model NCHESS2306)" [J].
Deshmukh, Akhil ;
Maiwall, Rakhi .
CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (02)
[28]   Validation of three non-invasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis B and C in Saudi Arabia [J].
Abdo, A. ;
Azzam, N. ;
Khalid, A. ;
Al Faleh, F. .
LIVER INTERNATIONAL, 2006, 26 :33-33
[29]   Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing [J].
Emrich, Tilman ;
Schattenberg, Jorn M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (02) :214-215
[30]   The diagnostic accuracy of non-invasive serum biomarkers for hepatic fibrosis in a cohort of patients with NAFLD [J].
Pecoraro, V. ;
Cuccorese, M. ;
Gabrielli, F. ;
Andreone, P. ;
Nascimbeni, F. ;
Trenti, T. .
CLINICA CHIMICA ACTA, 2024, 558 :76-76